Determination of the minimal important difference for the acute otitis media severity of symptom scale

Pediatric Infectious Disease Journal

Volumn 34, Issue 3, 2015, Pages e41-e43

  Shaikh, Nader ^a   Rockette, Howard E ^b   Hoberman, Alejandro ^a   Kurs Lasky, Marcia ^a   Paradise, Jack L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acute otitis media; Minimally important difference; Patient reported outcome; Severity of symptoms

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT;

ACUTE OTITIS MEDIA; ACUTE OTITIS MEDIA SEVERITY OF SYMPTOM SCALE; ANTIBIOTIC THERAPY; ARTICLE; ASSESSMENT OF HUMANS; CALCULATION; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MINIMAL IMPORTANT DIFFERENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOM; ACUTE DISEASE; CLINICAL TRIAL; FEMALE; INFANT; MALE; OTITIS MEDIA; PARENT; PRESCHOOL CHILD; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA; PARENTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84924280109     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000557     Document Type: Article

References (8)

1. US Department of Health and Human Services (USDHHS). Guidance for industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009; http://www.fda.gov/downloads/ Drugs/Guidances/UCM193282.pdf. Accessed September 25, 2013.
2. Wells G, Beaton D, Shea B, et al. Minimal clinically important differences: review of methods. J Rheumatol. 2001;28:406-412.
3. Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomised trials. BMJ. 1998;316:690-693.
4. Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res. 1996;5:35-46.
5. Shaikh N, Hoberman A, Paradise JL, et al. Responsiveness and construct validity of a symptom scale for acute otitis media. Pediatr Infect Dis J. 2009;28:9-12.
6. Shaikh N, Hoberman A, Paradise JL, et al. Development and preliminary evaluation of a parent-reported outcome instrument for clinical trials in acute otitis media. Pediatr Infect Dis J. 2009;28:5-8.
7. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364:105-115.
8. Kaiser L. Adjusting for baseline: change or percentage change? Stat Med. 1989;8:1183-1190.